Genomic characterization of Bordetella pertussis in South Africa, 2015-2019
- PMID: 38117675
- PMCID: PMC10763497
- DOI: 10.1099/mgen.0.001162
Genomic characterization of Bordetella pertussis in South Africa, 2015-2019
Abstract
Pertussis remains a public health concern in South Africa, with an increase in reported cases and outbreaks in recent years. Whole genome sequencing was performed on 32 Bordetella pertussis isolates sourced from three different surveillance programmes in South Africa between 2015 and 2019. Genome sequences were characterized using multilocus sequence typing, vaccine antigen genes (ptxP, ptxA, ptxB, prn and fimH) and overall genome structure. All isolates were sequence type 2 and harboured the pertussis toxin promoter allele ptxP3. The dominant genotype was ptxP3-ptxA1-ptxB2-prn2-fimH2 (31/32, 96.9 %), with no pertactin-deficient or other mutations in vaccine antigen genes identified. Amongst 21 isolates yielding closed genome assemblies, eight distinct genome structures were detected, with 61.9 % (13/21) of the isolates exhibiting three predominant structures. Increases in case numbers are probably not due to evolutionary changes in the genome but possibly due to other factors such as the cyclical nature of B. pertussis disease, waning immunity due to the use of acellular vaccines and/or population immunity gaps.
Keywords: B. pertussis; Illumina sequencing; PacBio sequencing; genome structural characterization; vaccine antigen genes; whole genome sequencing.
Conflict of interest statement
F.M. reports grants from Sanofi Pasteur. C.C. reports grants from Sanofi Pasteur, US Centers for Disease Control and Prevention, Wellcome, South African Medical Research Council and the Bill and Melinda Gates Foundation. A.vG. and N.W. report grants from Sanofi Pasteur and the Bill and Melinda Gates Foundation; M.C.N. reports grants from the Bill and Melinda Gates Foundation.
Figures


Similar articles
-
Genomic epidemiology and evolution of Bordetella pertussis under the vaccination pressure of acellular vaccines in Beijing, China, 2020-2023.Emerg Microbes Infect. 2025 Dec;14(1):2447611. doi: 10.1080/22221751.2024.2447611. Epub 2025 Jan 8. Emerg Microbes Infect. 2025. PMID: 39725566 Free PMC article.
-
Molecular epidemiology of Bordetella pertussis and analysis of vaccine antigen genes from clinical isolates from Shenzhen, China.Ann Clin Microbiol Antimicrob. 2021 Aug 18;20(1):53. doi: 10.1186/s12941-021-00458-3. Ann Clin Microbiol Antimicrob. 2021. PMID: 34407803 Free PMC article.
-
Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019.Eur J Clin Microbiol Infect Dis. 2022 Jun;41(6):913-924. doi: 10.1007/s10096-022-04453-0. Epub 2022 May 11. Eur J Clin Microbiol Infect Dis. 2022. PMID: 35543837 Free PMC article.
-
Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis.Emerg Infect Dis. 2021 Jun;27(6):1561-1566. doi: 10.3201/eid2706.203850. Emerg Infect Dis. 2021. PMID: 34014152 Free PMC article. Review.
-
Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.Expert Rev Vaccines. 2014 Sep;13(9):1135-46. doi: 10.1586/14760584.2014.932254. Epub 2014 Jun 23. Expert Rev Vaccines. 2014. PMID: 24953157 Review.
Cited by
-
Pertussis Outbreak During 2023 in Gipuzkoa, North Spain.Vaccines (Basel). 2024 Oct 18;12(10):1192. doi: 10.3390/vaccines12101192. Vaccines (Basel). 2024. PMID: 39460357 Free PMC article.
-
Vaccine antigen-based genotyping of Bordetella pertussis by direct Sanger sequencing of clinical samples in Peru from 2018 to 2019.Microbiol Spectr. 2025 Jun 3;13(6):e0200424. doi: 10.1128/spectrum.02004-24. Epub 2025 May 14. Microbiol Spectr. 2025. PMID: 40366145 Free PMC article.
-
Genomic epidemiology and evolution of Bordetella pertussis under the vaccination pressure of acellular vaccines in Beijing, China, 2020-2023.Emerg Microbes Infect. 2025 Dec;14(1):2447611. doi: 10.1080/22221751.2024.2447611. Epub 2025 Jan 8. Emerg Microbes Infect. 2025. PMID: 39725566 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical